HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

HANXBIO-B

28.880

-0.100-0.35%

Volume:400

Turnover:11.05K

Market Cap:3.87B

PE:-26.02

High:28.880

Open:27.220

Low:27.220

Close:28.980

52wk High:33.800

52wk Low:13.480

Shares:134.00M

HK Float Shares:134.00M

Volume Ratio:0.16

T/O Rate:0.00%

Dividend:- -

Dividend Rate:- -

EPS(LYR):-1.110

ROE:-27.27%

ROA:-12.63%

PB:5.23

PE(LYR):-26.02

PS:45303.02

Loading ...

Overview Company News Filings

HANXBIO-B Repurchases Shares Worth HK$1.02 Million on April 28

HANXBIO-B (03378) Allocates HK$1.06 Million for Share Buyback on April 27

Hanx Biopharma files HKEX next-day return, discloses HKD 27.85 share buyback

HANXBIO-B（03378）2025年经营表现与结构升级：研发投入加码，资产大幅提升

Bulletin Express

Hanx Biopharmaceuticals releases 2025 ESG report

Hanx Biopharmaceuticals publishes 2025 annual report

HANXBIO Executes HKD 1.06 Million Share Buyback, Lifts Treasury Stock to 0.25% of Mandated Limit

Bulletin Express

HANXBIO-B (03378) Unveils Four Key Preclinical Research Findings at 2026 AACR Annual Meeting

Hanx Biopharmaceuticals says HX044 enters Phase I after positive preclinical data at AACR

HANXBIO-B spends HKD 0.99 million to repurchase 31,200 H shares; outstanding shares (ex-treasury) trimmed to 135.94 million

Bulletin Express

HANXBIO-B (03378) Allocates HK$988,500 for Share Buyback on April 22

Hanx Biopharma buys back 2,100 H-shares; treasury stock climbs to 246,000

Bulletin Express

Hanx Biopharmaceuticals Triggers Share Buyback; 23,000 H Shares Repurchased for HKD 0.68 Million

Bulletin Express

HANXBIO-B (03378) Repurchases 23,000 Shares for HK$684,600 on April 17

Hanx Biopharmaceuticals Completes HKD 0.59 Million Share Buyback, Lifting Treasury Shares to 220,900

Bulletin Express

HANXBIO-B Allocates Approximately HK$619,900 for Share Buyback on April 15

Hanx Biopharmaceuticals buys back 21,500 H-shares, treasury stock rises to 200,800

Bulletin Express

HANXBIO-B (03378) Repurchases 23,500 Shares for HK$683,100 on April 14

Hanx Biopharmaceuticals executes HK$0.72 million share buyback, raises treasury stock to 109,800 shares

Bulletin Express

Hanx Biopharmaceuticals completes HKD 1.37 million share buyback, boosts treasury stock to 155,800 H-shares

Bulletin Express

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://hk.tigershowtime.com/stock/03378/news?page=7"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"03378","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"03378\",,,,,undefined,":{"symbol":"03378","market":"HK","secType":"STK","nameCN":"HANXBIO-B","latestPrice":28.88,"timestamp":1790910597265,"preClose":28.98,"halted":0,"volume":400,"delay":0,"changeRate":-0.003450655624568717,"floatShares":134000000,"shares":134000000,"eps":-1.11,"marketStatus":"Noon Closed","change":-0.1,"latestTime":"10-02 11:09:57","open":27.22,"high":28.88,"low":27.22,"amount":11054,"amplitude":0.057281,"askPrice":28.9,"askSize":400,"bidPrice":27.82,"bidSize":200,"shortable":0,"etf":0,"ttmEps":-1.129,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1790917200000},"marketStatusCode":3,"adr":0,"listingDate":1766419200000,"exchange":"SEHK","adjPreClose":28.98,"openAndCloseTimeList":[[1790904600000,1790913600000],[1790917200000,1790928000000]],"volumeRatio":0.162963,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"03378\",,,,,undefined,":{"symbol":"03378","floatShares":134000000,"roa":"-12.63%","roe":"-27.27%","lyrEps":-1.11,"volumeRatio":0.162963,"shares":134000000,"dividePrice":0,"high":28.88,"amplitude":0.057281,"preClose":28.98,"low":27.22,"week52Low":13.48,"pbRate":"5.23","psRate":"45303.02","week52High":33.8,"institutionHeld":0,"latestPrice":28.88,"committee":-0.333333,"eps":-1.11,"divideRate":0,"volume":400,"delay":0,"ttmEps":-1.129,"open":27.22,"prevYearClose":15.98,"prevWeekClose":28.06,"prevMonthClose":28.98,"prevQuarterClose":28.98,"fiveDayClose":28,"twentyDayClose":28.8,"sixtyDayClose":28.6},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/03378\",params:#limit:5,,,undefined,":[{"date":"2026-08-17","symbol":"03378","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1786930200000,"name":null,"time":"","dateTimestamp":1786896000000,"actualEps":null},{"date":"2026-03-27","symbol":"03378","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774575000000,"name":null,"time":"","dateTimestamp":1774540800000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"03378\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"03378\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/03378\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"03378","date":"2026-09-30","current":-25.668733,"percent":0.2025,"low":-33.201019,"twenty":-25.690089,"median":4.65123,"eighty":5.248131,"high":11.144666,"avg":-7.81462,"sd":15.536733,"marketCap":3947621693},"quantilePoints":[{"date":"2021-10-08","current":5.316326,"twenty":6.147257,"median":8.853246,"eighty":10.544157,"marketCap":2344532000},{"date":"2021-10-15","current":5.374457,"twenty":6.140429,"median":8.815924,"eighty":10.511884,"marketCap":2371794000},{"date":"2021-10-22","current":5.27481,"twenty":6.127225,"median":8.797247,"eighty":10.493516,"marketCap":2344532000},{"date":"2021-10-29","current":5.349373,"twenty":6.119344,"median":8.779365,"eighty":10.475509,"marketCap":2371794000},{"date":"2021-11-05","current":4.889355,"twenty":6.114079,"median":8.748721,"eighty":10.420921,"marketCap":2208222000},{"date":"2021-11-12","current":4.809165,"twenty":6.108215,"median":8.717377,"eighty":10.3914,"marketCap":2180960000},{"date":"2021-11-19","current":4.876179,"twenty":6.101111,"median":8.695621,"eighty":10.35108,"marketCap":2208222000},{"date":"2021-11-26","current":4.87462,"twenty":6.084623,"median":8.671197,"eighty":10.318496,"marketCap":2208222000},{"date":"2021-12-03","current":5.22604,"twenty":6.078106,"median":8.624866,"eighty":10.2832,"marketCap":2371794000},{"date":"2021-12-10","current":5.037231,"twenty":6.070936,"median":8.60024,"eighty":10.227378,"marketCap":2290008000},{"date":"2021-12-17","current":4.86069,"twenty":6.054857,"median":8.564239,"eighty":10.190552,"marketCap":2208222000},{"date":"2021-12-24","current":4.916003,"twenty":6.052379,"median":8.514295,"eighty":10.154612,"marketCap":2235484000},{"date":"2021-12-31","current":5.144618,"twenty":6.047568,"median":8.504328,"eighty":10.145926,"marketCap":2344532000},{"date":"2022-01-07","current":5.164225,"twenty":6.042847,"median":8.4784,"eighty":10.143723,"marketCap":2344532000},{"date":"2022-01-14","current":5.093083,"twenty":6.038396,"median":8.458041,"eighty":10.124223,"marketCap":2317270000},{"date":"2022-01-21","current":5.380359,"twenty":6.023881,"median":8.434699,"eighty":10.073347,"marketCap":2453580000},{"date":"2022-01-28","current":5.034519,"twenty":6.017531,"median":8.407204,"eighty":10.033216,"marketCap":2290008000},{"date":"2022-02-04","current":5.156916,"twenty":6.014762,"median":8.39643,"eighty":10.012135,"marketCap":2344532000},{"date":"2022-02-11","current":5.206364,"twenty":6.007032,"median":8.358349,"eighty":9.99186,"marketCap":2371794000},{"date":"2022-02-18","current":5.240469,"twenty":5.997462,"median":8.310368,"eighty":9.985006,"marketCap":2399056000},{"date":"2022-02-25","current":4.989965,"twenty":5.989585,"median":8.200753,"eighty":9.95781,"marketCap":2290008000},{"date":"2022-03-04","current":4.928672,"twenty":5.979555,"median":8.170117,"eighty":9.938791,"marketCap":2262746000},{"date":"2022-03-11","current":4.876653,"twenty":5.973297,"median":8.123652,"eighty":9.894296,"marketCap":2235484000},{"date":"2022-03-18","current":4.717047,"twenty":5.960037,"median":8.070293,"eighty":9.868408,"marketCap":2153698000},{"date":"2022-03-25","current":5.194505,"twenty":5.957174,"median":8.005027,"eighty":9.829511,"marketCap":2371794000},{"date":"2022-04-01","current":4.531371,"twenty":5.948529,"median":7.973288,"eighty":9.81982,"marketCap":2317270000},{"date":"2022-04-08","current":4.649157,"twenty":5.946479,"median":7.953215,"eighty":9.804315,"marketCap":2371794000},{"date":"2022-04-14","current":4.707815,"twenty":5.940486,"median":7.879016,"eighty":9.79455,"marketCap":2399056000},{"date":"2022-04-22","current":4.802247,"twenty":5.934888,"median":7.843904,"eighty":9.78108,"marketCap":2399056000},{"date":"2022-04-29","current":4.825339,"twenty":5.919008,"median":7.698315,"eighty":9.768722,"marketCap":2371794000},{"date":"2022-05-06","current":4.410489,"twenty":5.9041,"median":7.676819,"eighty":9.755607,"marketCap":2399056000},{"date":"2022-05-13","current":4.541874,"twenty":5.900202,"median":7.615768,"eighty":9.747897,"marketCap":2426318000},{"date":"2022-05-20","current":6.290771,"twenty":5.897549,"median":7.514446,"eighty":9.724288,"marketCap":3407750000},{"date":"2022-05-27","current":7.303631,"twenty":5.895161,"median":7.434402,"eighty":9.709875,"marketCap":3952990000},{"date":"2022-06-02","current":7.264641,"twenty":5.89518,"median":7.334535,"eighty":9.703749,"marketCap":3952990000},{"date":"2022-06-10","current":10.869875,"twenty":5.895161,"median":7.322855,"eighty":9.700394,"marketCap":5888592000},{"date":"2022-06-17","current":10.755528,"twenty":5.895161,"median":7.322855,"eighty":9.700394,"marketCap":5806806000},{"date":"2022-06-24","current":10.662581,"twenty":5.895161,"median":7.322855,"eighty":9.700394,"marketCap":5779544000},{"date":"2022-06-30","current":10.731352,"twenty":5.895161,"median":7.322855,"eighty":9.700394,"marketCap":5806806000},{"date":"2022-07-08","current":10.820976,"twenty":5.895141,"median":7.321962,"eighty":9.698882,"marketCap":5861330000},{"date":"2022-07-15","current":10.871399,"twenty":5.895141,"median":7.321962,"eighty":9.698882,"marketCap":5834068000},{"date":"2022-07-22","current":10.864271,"twenty":5.895141,"median":7.321962,"eighty":9.698882,"marketCap":5834068000},{"date":"2022-07-29","current":11.058353,"twenty":5.895141,"median":7.321962,"eighty":9.698882,"marketCap":5943116000},{"date":"2022-08-05","current":11.082085,"twenty":5.895141,"median":7.321962,"eighty":9.698882,"marketCap":5943116000},{"date":"2022-08-29","current":10.115403,"twenty":5.888507,"median":7.263276,"eighty":9.659414,"marketCap":6079426000},{"date":"2022-09-23","current":10.460916,"twenty":5.875785,"median":7.121577,"eighty":9.631568,"marketCap":6106688000},{"date":"2022-09-27","current":10.715865,"twenty":5.875785,"median":7.121577,"eighty":9.635273,"marketCap":6106688000},{"date":"2025-12-24","current":-18.447668,"twenty":4.982674,"median":6.211114,"eighty":10.220738,"marketCap":2368845453},{"date":"2026-01-02","current":-18.02665,"twenty":4.940407,"median":6.084014,"eighty":10.228734,"marketCap":2323893239},{"date":"2026-01-09","current":-17.992416,"twenty":4.931186,"median":6.014515,"eighty":10.205703,"marketCap":2325255428},{"date":"2026-01-16","current":-17.923631,"twenty":4.916421,"median":5.897664,"eighty":10.160138,"marketCap":2323893239},{"date":"2026-01-23","current":-17.982908,"twenty":4.885478,"median":5.797377,"eighty":10.160138,"marketCap":2329341993},{"date":"2026-01-30","current":-17.744046,"twenty":4.875244,"median":5.725499,"eighty":10.160138,"marketCap":2308909168},{"date":"2026-02-06","current":-16.811585,"twenty":4.866613,"median":5.578062,"eighty":10.122459,"marketCap":2193123163},{"date":"2026-02-13","current":-19.892571,"twenty":4.857721,"median":5.514388,"eighty":9.398557,"marketCap":2609952782},{"date":"2026-02-20","current":-19.63014,"twenty":4.838987,"median":5.394615,"eighty":9.188636,"marketCap":2571811510},{"date":"2026-02-27","current":-18.008211,"twenty":4.809165,"median":5.349373,"eighty":9.115992,"marketCap":2385191713},{"date":"2026-03-06","current":-19.720151,"twenty":4.794539,"median":5.318493,"eighty":9.039595,"marketCap":2590882146},{"date":"2026-03-13","current":-19.154995,"twenty":4.734025,"median":5.280689,"eighty":8.898598,"marketCap":2528221484},{"date":"2026-03-20","current":-24.324826,"twenty":4.717047,"median":5.27512,"eighty":8.792193,"marketCap":3198418128},{"date":"2026-03-27","current":-29.829257,"twenty":4.666438,"median":5.249923,"eighty":8.559172,"marketCap":3912204797},{"date":"2026-04-02","current":-33.201019,"twenty":4.649572,"median":5.228098,"eighty":8.438047,"marketCap":4375348819},{"date":"2026-04-10","current":-30.874905,"twenty":4.56464,"median":5.211517,"eighty":8.156734,"marketCap":4100186783},{"date":"2026-04-17","current":-28.990908,"twenty":4.497397,"median":5.194059,"eighty":7.9968,"marketCap":4356278183},{"date":"2026-04-24","current":-26.124785,"twenty":-15.418367,"median":5.160571,"eighty":7.807328,"marketCap":3925826680},{"date":"2026-04-30","current":-28.728082,"twenty":-16.801754,"median":5.147581,"eighty":7.337697,"marketCap":4318136911},{"date":"2026-05-08","current":-29.080272,"twenty":-17.535098,"median":5.128333,"eighty":7.264368,"marketCap":4386246326},{"date":"2026-05-15","current":-25.905424,"twenty":-17.807067,"median":5.103123,"eighty":7.202337,"marketCap":3917653550},{"date":"2026-05-22","current":-25.748089,"twenty":-17.879019,"median":5.092409,"eighty":6.915003,"marketCap":3884961031},{"date":"2026-05-29","current":-25.712847,"twenty":-17.93488,"median":5.048821,"eighty":6.718284,"marketCap":3893134161},{"date":"2026-06-05","current":-24.938916,"twenty":-18.015587,"median":5.038323,"eighty":6.588315,"marketCap":3781434720},{"date":"2026-06-12","current":-24.14671,"twenty":-18.118353,"median":5.023214,"eighty":6.365684,"marketCap":3658837773},{"date":"2026-06-18","current":-24.124788,"twenty":-18.283036,"median":4.995209,"eighty":6.290771,"marketCap":3664286527},{"date":"2026-06-26","current":-23.468119,"twenty":-18.694621,"median":4.985606,"eighty":6.218847,"marketCap":3547138333},{"date":"2026-07-03","current":-26.026177,"twenty":-19.36707,"median":4.949882,"eighty":6.211114,"marketCap":3936724187},{"date":"2026-07-10","current":-26.148322,"twenty":-19.720151,"median":4.931815,"eighty":6.084012,"marketCap":3950346070},{"date":"2026-07-17","current":-25.750118,"twenty":-23.468119,"median":4.916526,"eighty":5.905983,"marketCap":3904031667},{"date":"2026-07-24","current":-24.163383,"twenty":-23.965295,"median":4.886124,"eighty":5.872595,"marketCap":3664286527},{"date":"2026-07-31","current":-25.605863,"twenty":-24.07378,"median":4.876179,"eighty":5.805676,"marketCap":3890409784},{"date":"2026-08-07","current":-25.770999,"twenty":-24.130978,"median":4.866283,"eighty":5.627239,"marketCap":3923102304},{"date":"2026-08-14","current":-27.150453,"twenty":-24.332526,"median":4.857543,"eighty":5.519282,"marketCap":4138328055},{"date":"2026-08-21","current":-27.786128,"twenty":-24.640614,"median":4.815493,"eighty":5.392136,"marketCap":4244578742},{"date":"2026-08-28","current":-27.384112,"twenty":-24.995147,"median":4.805527,"eighty":5.364423,"marketCap":4198264340},{"date":"2026-09-04","current":-25.738908,"twenty":-25.519857,"median":4.788207,"eighty":5.342295,"marketCap":3947621693},{"date":"2026-09-11","current":-24.302816,"twenty":-25.582443,"median":4.733325,"eighty":5.316132,"marketCap":3732395942},{"date":"2026-09-18","current":-24.944316,"twenty":-25.671123,"median":4.713496,"eighty":5.275921,"marketCap":3835922252},{"date":"2026-09-25","current":-24.903198,"twenty":-25.690089,"median":4.662971,"eighty":5.271976,"marketCap":3822300369},{"date":"2026-09-30","current":-25.671803,"twenty":-25.690089,"median":4.65123,"eighty":5.248131,"marketCap":3947621693}],"updateTime":1790872895456},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"03378\",pageSize:20,pageCount:7,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1121933131","title":"HANXBIO-B Repurchases Shares Worth HK$1.02 Million on April 28","url":"https://stock-news.laohu8.com/highlight/detail?id=1121933131","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1121933131?lang=en_us&edition=fundamental","pubTime":"2026-04-28 19:54","pubTimestamp":1777377250,"startTime":"0","endTime":"0","summary":"HANXBIO-B (03378) announced that on April 28, 2026, the company repurchased 34,900 shares at a cost of approximately HK$1.02 million. The repurchase price ranged between HK$28 and HK$30 per share.","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1535","03378","BK1161","BK1173"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1101552983","title":"HANXBIO-B (03378) Allocates HK$1.06 Million for Share Buyback on April 27","url":"https://stock-news.laohu8.com/highlight/detail?id=1101552983","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1101552983?lang=en_us&edition=fundamental","pubTime":"2026-04-27 20:22","pubTimestamp":1777292569,"startTime":"0","endTime":"0","summary":"HANXBIO-B (03378) announced that on April 27, 2026, the company executed a share repurchase, spending HK$1.06 million to buy back 38,000 shares. The repurchase price ranged from HK$26.50 to HK$28.58 per share.","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03378","BK1161","BK1173","BK1535"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630396042","title":"Hanx Biopharma files HKEX next-day return, discloses HKD 27.85 share buyback","url":"https://stock-news.laohu8.com/highlight/detail?id=2630396042","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630396042?lang=en_us&edition=fundamental","pubTime":"2026-04-27 20:13","pubTimestamp":1777292021,"startTime":"0","endTime":"0","summary":"Hanx Biopharmaceuticals filed a next-day disclosure return reporting a repurchase of 38,000 H shares on April 27.Buyback price ranged from HKD 26.5 to HKD 28.58 per share.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hanx Biopharmaceuticals  Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on April 27, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260427:nNDL5zZ0R3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03378","BK1161","BK1173","BK1535"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1196859272","title":"HANXBIO-B（03378）2025年经营表现与结构升级：研发投入加码，资产大幅提升","url":"https://stock-news.laohu8.com/highlight/detail?id=1196859272","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1196859272?lang=en_us&edition=fundamental","pubTime":"2026-04-27 17:50","pubTimestamp":1777283446,"startTime":"0","endTime":"0","summary":"2025年度，Hanx Biopharmaceuticals (Wuhan) Co.,...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"HANXBIO-B（03378）2025年经营表现与结构升级：研发投入加码，资产大幅提升","news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03378"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630736499","title":"Hanx Biopharmaceuticals releases 2025 ESG report","url":"https://stock-news.laohu8.com/highlight/detail?id=2630736499","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630736499?lang=en_us&edition=fundamental","pubTime":"2026-04-27 17:46","pubTimestamp":1777283188,"startTime":"0","endTime":"0","summary":"Hanx Biopharmaceuticals reported FY 2025 Scope 2 greenhouse-gas emissions of 137.76 tonnes CO2e.Scope 3 emissions totaled 132.96 tonnes CO2e, taking combined Scope 2 and 3 emissions to 270.72 tonnes CO2e.Electricity consumption rose to 256,722 kWh from 221,255 kWh.Water consumption increased to 2,066 tonnes from 619 tonnes.Hazardous waste discharged climbed to 0.72 tonnes from 0.41 tonnes.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hanx Biopharmaceuticals  Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on April 27, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260427:nNDL5KHwj7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","03378","BK1173","BK1535"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630364911","title":"Hanx Biopharmaceuticals publishes 2025 annual report","url":"https://stock-news.laohu8.com/highlight/detail?id=2630364911","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630364911?lang=en_us&edition=fundamental","pubTime":"2026-04-27 17:45","pubTimestamp":1777283109,"startTime":"0","endTime":"0","summary":"Hanx Biopharmaceuticals released annual report for year ended Dec. 31, 2025, highlighting transition into capital markets following Hong Kong listing under stock code 3378.R&D focus stayed on immuno-oncology, ADCs, autoimmune diseases, with pipeline positioned as three clinical-stage candidates plus one IND-stage asset.Flagship HX009 advanced with positive interim efficacy signals in EBV-positive lymphoma, acral or mucosal melanoma.CTLA-4/SIRPα fusion protein HX044 expanded global development with parallel enrollment in China, Australia, targeting ICI-resistant solid tumors.First ADC candidate HX111, targeting OX40, secured NMPA IND clearance, with first-in-human trial planned in early 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advic","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260427:nNDLb7kN6f:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1173","03378","BK1161","BK1535"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1182854264","title":"HANXBIO Executes HKD 1.06 Million Share Buyback, Lifts Treasury Stock to 0.25% of Mandated Limit","url":"https://stock-news.laohu8.com/highlight/detail?id=1182854264","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1182854264?lang=en_us&edition=fundamental","pubTime":"2026-04-24 21:03","pubTimestamp":1777035807,"startTime":"0","endTime":"0","summary":"Hanx Biopharmaceuticals (Wuhan) Co., Ltd. (HANXBIO; H-share) disclosed a share repurchase on 24 April 2026, reducing its outstanding share count and increasing treasury stock as follows: •...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03378"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1154342285","title":"HANXBIO-B (03378) Unveils Four Key Preclinical Research Findings at 2026 AACR Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=1154342285","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1154342285?lang=en_us&edition=fundamental","pubTime":"2026-04-24 21:02","pubTimestamp":1777035779,"startTime":"0","endTime":"0","summary":"HANXBIO-B (03378) announced that the company presented four core preclinical research results in poster sessions at the 2026 American Association for Cancer Research (AACR) Annual Meeting, held from...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1535","03378","BK1161","BK1173"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629841980","title":"Hanx Biopharmaceuticals says HX044 enters Phase I after positive preclinical data at AACR","url":"https://stock-news.laohu8.com/highlight/detail?id=2629841980","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629841980?lang=en_us&edition=fundamental","pubTime":"2026-04-24 20:49","pubTimestamp":1777034990,"startTime":"0","endTime":"0","summary":"Hanx Biopharmaceuticals presented four oncology R&D posters at 2026 AACR annual meeting held April 17-22 in San Diego.Preclinical findings supported clinical development of HX044, a CTLA-4 x CD47 program now in Phase I, with modeling suggesting a wider therapeutic window versus ipilimumab.Separate preclinical posters on PD-L1-focused antibody-drug conjugates, including HX116 and HX112, indicated tumor-targeted activity in 3D tumor organoid testing with potential for improved specificity versus a leading clinical comparator.Hanx also highlighted a 3D tumor organoid evaluation platform positioned as more predictive of in vivo anti-tumor effects than conventional 2D cell assays, aiming to streamline ADC candidate selection.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financi","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260424:nNDL4bcfXd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1173","BK1161","BK1535","03378"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1176038362","title":"HANXBIO-B spends HKD 0.99 million to repurchase 31,200 H shares; outstanding shares (ex-treasury) trimmed to 135.94 million","url":"https://stock-news.laohu8.com/highlight/detail?id=1176038362","media":"Bulletin Express","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1176038362?lang=en_us&edition=fundamental","pubTime":"2026-04-22 20:23","pubTimestamp":1776860601,"startTime":"0","endTime":"0","summary":"Hanx Biopharmaceuticals (Wuhan) Co., Ltd. (HANXBIO-B) disclosed that on 22 April 2026 it bought back 31,200 H shares on the Hong Kong Stock Exchange. The transaction was executed within a price range...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03378"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1165240691","title":"HANXBIO-B (03378) Allocates HK$988,500 for Share Buyback on April 22","url":"https://stock-news.laohu8.com/highlight/detail?id=1165240691","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1165240691?lang=en_us&edition=fundamental","pubTime":"2026-04-22 20:21","pubTimestamp":1776860460,"startTime":"0","endTime":"0","summary":"HANXBIO-B (03378) announced that on April 22, the company executed a share repurchase, spending HK$988,500 to buy back 31,200 shares. The repurchase price ranged between HK$31.18 and HK$31.98 per share.","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1173","BK1535","BK1161","03378"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132596082","title":"Hanx Biopharma buys back 2,100 H-shares; treasury stock climbs to 246,000","url":"https://stock-news.laohu8.com/highlight/detail?id=1132596082","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1132596082?lang=en_us&edition=fundamental","pubTime":"2026-04-21 19:23","pubTimestamp":1776770621,"startTime":"0","endTime":"0","summary":"Hanx Biopharmaceuticals (Wuhan) Co., Ltd. disclosed that it repurchased 2,100 H-shares on 21 April 2026, according to its Next Day Disclosure Return filed with the Hong Kong Stock Exchange on the...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03378"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1174704383","title":"Hanx Biopharmaceuticals Triggers Share Buyback; 23,000 H Shares Repurchased for HKD 0.68 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=1174704383","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1174704383?lang=en_us&edition=fundamental","pubTime":"2026-04-17 20:07","pubTimestamp":1776427629,"startTime":"0","endTime":"0","summary":"Hanx Biopharmaceuticals (Wuhan) Co., Ltd. executed an on-market repurchase of 23,000 H shares on 17 April 2026, according to its Next Day Disclosure Return filed with the Hong Kong Stock Exchange on...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03378"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1165296893","title":"HANXBIO-B (03378) Repurchases 23,000 Shares for HK$684,600 on April 17","url":"https://stock-news.laohu8.com/highlight/detail?id=1165296893","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1165296893?lang=en_us&edition=fundamental","pubTime":"2026-04-17 19:50","pubTimestamp":1776426657,"startTime":"0","endTime":"0","summary":"HANXBIO-B (03378) announced that on April 17, 2026, the company repurchased 23,000 of its own shares at a total cost of approximately HK$684,600.","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1535","BK1161","BK1173","03378"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1111330059","title":"Hanx Biopharmaceuticals Completes HKD 0.59 Million Share Buyback, Lifting Treasury Shares to 220,900","url":"https://stock-news.laohu8.com/highlight/detail?id=1111330059","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1111330059?lang=en_us&edition=fundamental","pubTime":"2026-04-16 20:03","pubTimestamp":1776341002,"startTime":"0","endTime":"0","summary":"Hanx Biopharmaceuticals (Wuhan) Co., Ltd. executed an on-market repurchase of 20,100 H shares on 16 April 2026, paying a total of HKD 0.59 million at prices ranging from HKD 28.48 to HKD 30.00 per...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03378"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1140801564","title":"HANXBIO-B Allocates Approximately HK$619,900 for Share Buyback on April 15","url":"https://stock-news.laohu8.com/highlight/detail?id=1140801564","media":"Deep News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1140801564?lang=en_us&edition=fundamental","pubTime":"2026-04-16 08:51","pubTimestamp":1776300680,"startTime":"0","endTime":"0","summary":"HANXBIO-B (03378) announced that on April 15, 2026, the company repurchased 21,500 shares at a total cost of approximately HK$619,900.","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1535","BK1161","03378","BK1173"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1158866997","title":"Hanx Biopharmaceuticals buys back 21,500 H-shares, treasury stock rises to 200,800","url":"https://stock-news.laohu8.com/highlight/detail?id=1158866997","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1158866997?lang=en_us&edition=fundamental","pubTime":"2026-04-15 22:04","pubTimestamp":1776261880,"startTime":"0","endTime":"0","summary":"Hanx Biopharmaceuticals (Wuhan) Co., Ltd. (HANXBIO-B) disclosed a Next Day Disclosure Return stating that it repurchased 21,500 H-shares on 15 April 2026 via on-market transactions on the Hong Kong...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03378"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1101475745","title":"HANXBIO-B (03378) Repurchases 23,500 Shares for HK$683,100 on April 14","url":"https://stock-news.laohu8.com/highlight/detail?id=1101475745","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1101475745?lang=en_us&edition=fundamental","pubTime":"2026-04-14 22:44","pubTimestamp":1776177867,"startTime":"0","endTime":"0","summary":"HANXBIO-B (03378) announced that on April 14, the company repurchased 23,500 of its own shares at a total cost of approximately HK$683,100.","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1535","BK1161","03378","BK1173"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1176436451","title":"Hanx Biopharmaceuticals executes HK$0.72 million share buyback, raises treasury stock to 109,800 shares","url":"https://stock-news.laohu8.com/highlight/detail?id=1176436451","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1176436451?lang=en_us&edition=fundamental","pubTime":"2026-04-14 22:43","pubTimestamp":1776177780,"startTime":"0","endTime":"0","summary":"Hanx Biopharmaceuticals (Wuhan) Co., Ltd. repurchased 23,700 H-shares on 10 April 2026 via on-exchange transactions, paying an average HK$30.18 per share within a price range of HK$29.50–30.66. The...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03378"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1154449304","title":"Hanx Biopharmaceuticals completes HKD 1.37 million share buyback, boosts treasury stock to 155,800 H-shares","url":"https://stock-news.laohu8.com/highlight/detail?id=1154449304","media":"Bulletin Express","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1154449304?lang=en_us&edition=fundamental","pubTime":"2026-04-14 22:42","pubTimestamp":1776177774,"startTime":"0","endTime":"0","summary":"Hanx Biopharmaceuticals (Wuhan) Co., Ltd. disclosed that it repurchased 46,000 H-shares on 13 April 2026 through on-market transactions. The buyback was executed within a price range of HKD...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03378"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":8,"pageCount":7,"totalSize":149,"code":"91000000","status":"200"}]}}